Hunter R. Sharp - McDermott Will & Emery


Hunter Sharp focuses his practice on complex domestic and cross-border transactional matters. He represents private equity firms, family offices and strategic investors in the structuring and negotiation of leveraged buyouts, mergers, acquisitions, joint ventures, growth equity and venture capital investments, divestitures and other general corporate and governance matters.

Hunter has experience across a variety of industries, including healthcare, life sciences, basic industries, consumer goods, packaging, IT outsourcing, real estate services, manufacturing and business services.

Show More


  • Ampersand Capital in a variety of transactions and ongoing portfolio company work, including the acquisitions of Cadence Fluidics and Pharma Packaging Solutions, the sale of Adaptas Solutions to IMI Plc, and a growth investment in AcuraBio, a leading Australian biopharmaceutical CDMO.
  • Amulet Capital in the acquisition of United Vein & Vascular Centers.
  • Enhanced Healthcare Partners in a wide variety of transactions including the merger of Prospira PainCare with National Spine and Pain, the platform investment in Howard J. Chudler & Associates, a provider of autism therapy, and a growth investment in Vytalize Health.
  • Lindsay Goldberg in a variety of transactions, including the sale of Women’s Care Enterprises to BC Partners, the sale of PT Solutions to General Atlantic, and the formation of its Doppler Veterinary Network platform and associated acquisitions of veterinary practices in multiple states.

Show More


Emory University School of Law, JD, with honors, 2010
Vanderbilt University, BS, magna cum laude, 2006